Gavin Hilary James Wood's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 96,000 Ordinary Shares with a nominal value of GBP0.001 per share done at an average price of $0.0 . Disclosure was reported to the exchange on Sept. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics Plc | Gavin Hilary James Wood | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.01 per share. | 02 Sep 2025 | 96,000 | 0 (0%) | 0% | 0.0 | 950 | Ordinary Shares with a nominal value of GBP0.001 per share |
Adaptimmune Therapeutics Plc | Gavin Hilary James Wood | Chief Financial Officer | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | ||
Adaptimmune Therapeutics Plc | Gavin Hilary James Wood | Chief Financial Officer | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares |